Understanding the precancerous nature of AKs and their relationship to cancer
Hearing "precancerous" from your dermatologist can be alarming, especially when the word "cancer" is right there in it. But an actinic keratosis (AK) and skin cancer are not the same diagnosis, and understanding the difference — and why the line between them exists — can make the whole conversation about monitoring and treatment feel much less frightening.
This article walks through what an AK actually is at the cellular level, how that compares to squamous cell carcinoma (SCC), and why your dermatologist treats AKs the way they do.
Years of ultraviolet (UV) exposure can damage the DNA inside keratinocytes, the cells that make up the outermost layer of skin (the epidermis). An actinic keratosis forms when a patch of these damaged cells grows abnormally — but stays contained within the epidermis, never breaking through the basement membrane into the deeper dermis below.
That containment is the key concept. AAD clinical guidelines describe AK as an early, in situ stage of keratinocyte damage — the cells are abnormal and capable of progressing further, but they haven't yet invaded surrounding tissue, which is what defines a cancer.
The distinction comes down to one word: invasion. Think of the epidermis and dermis as two floors of a building, separated by a floor (the basement membrane).
Abnormal cells stay on the top floor — confined to the epidermis. The patch is rough, scaly, and typically flat or only slightly raised. It cannot spread to lymph nodes or other organs because it has no access to blood vessels or lymphatic channels, which live in the dermis below.
The abnormal cells break through the floor and invade the dermis, where they can access blood vessels and lymphatics. This is what makes it a true cancer — it has the biological capacity to grow more aggressively, damage surrounding tissue, and in some cases spread (metastasize) beyond the original site.
Some pathologists describe a very thick or long-standing AK as sitting at the edge of this spectrum, sometimes labeled "AK with early or focal invasion" once a biopsy shows cells have started to cross that boundary — which is exactly why a changing or thickening AK often prompts a biopsy rather than continued watching.
Not every AK is destined to become cancer — most never do. A systematic review of the natural history of untreated AK found that estimates of progression to squamous cell carcinoma vary widely between studies, but the risk for any single lesion, tracked over one year, is generally low.
The risk isn't zero, though, and it accumulates: someone with dozens of AKs across sun-damaged skin carries meaningfully more cumulative risk than someone with a single small patch. That's the reasoning behind treating AKs at all, rather than simply waiting to see which ones change.
Because the difference between AK and SCC is about invasion — something you can't see with the naked eye — your dermatologist relies on certain clinical clues to decide whether a spot needs a biopsy rather than routine treatment:
None of these signs alone confirms cancer — only a biopsy can do that — but any of them is a reason to have a spot checked rather than continuing to watch it.
An actinic keratosis is a warning sign written on your skin by years of sun exposure — abnormal cells that are still contained, not yet a cancer. That containment is exactly what treatment aims to preserve: catching and clearing AKs before any of them has the chance to cross into the deeper skin and become a squamous cell carcinoma.
The takeaway isn't to panic over a diagnosis of AK — it's to treat it as the clear, actionable opportunity it is: a chance to intervene well before cancer is on the table.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Only a dermatologist examining your skin in person — sometimes with a biopsy — can determine whether a specific spot is an actinic keratosis, a skin cancer, or something else.
Chat with our AI guide for personalized information about actinic keratosis and skin cancer
Chat with the Navigator